Member Info for iriz

Accrufer price per capsule has jumped from $8.47 to $8.98 since 10th Jan 2024. The prices are before rebate is applied.

https://public.tableau.com/app/profile/ben.link/viz/DrugPricingNADACDashboard_16656685650270/Dashboard1

WAC is up 6% in first week of January based on Medicaid Spent data.

https://public.tableau.com/app/profile/ben.link/viz/BrandDrugListPriceChangeBoxScore/BoxScore

Published last week upto 05/01/2024. Filter it by drug maker (Shield Tx)

https://public.tableau.com/app/profile/ben.link/viz/BrandDrugListPriceChangeBoxScore/BoxScore

It's back again

Reminds me of Diurnal. Price crashed, then director buys followed by big million buys and then sold on 150% premium after a week.

Looks like it is following Diurnal footsteps

1.7 million buys on late Friday were possibly from Premier Miton Group plc. Now holding 5.4%

10 million and 7 million buys in closing hours..

Revenue for 2022 is going to be around 8 million. STX can easily arrange RBF loan of upto 4 to 5 times their revenue.
The financing model is similar to a capital repayment mortgage. You pay back capital plus interest every month. If revenue is increasing, you can borrow more.
Even with H1, 2022 revenue numbers, they can easily borrow 10 million. The process is simpler than mortgage application.
All they need is revenue numbers to apply!!

Cash on 31st August, 2022 was £8.2 million. With cash burn @ 1.5 million, it's going last beyond January, 2023.
Any upside on Q3 sales will take it beyond February, 2023.

Series - A startups can easily raise $20-30 million in US market by showing growth. STX is a fast growing FDA approved drug with prescription numbers rising quarter to quarter so is the QRR. I don't see any reason why STX cannot raise $20-30 million in US market.

The panic selling here is due to shareprophet article which is owned by some Canadian citizen with just £85k in it's account according to company house details.

https://www.bloomberg.com/news/articles/2022-10-28/nextera-to-buy-1-1-billion-landfill-gas-to-electric-portfolio?leadSource=uverify%20wall

DarkHero1981

The RNS did mention "drawn down" which by definition can be withdrawn in chunks.

"Drawdown Loan allows you to borrow 'in chunks' and repay the full amount borrowed"

"Drawdown Loan allows you to borrow 'in chunks' and repay the full amount borrowed"

Great news. With another market covered, it will definitely help in arranging non-dilutive finance.

STX will not draw down the whole $10 million in August. It will do it in chunks. It needs 3-4m to get to October when it can show the path to profitability and arrange non-dilutive finance on good terms. Those who are speculating on different channels that AOP will own 50% shares by 10th August are just trying to convince you to sell. AOP converting 3-4m options at a much higher price won't be a big dilution.

Amazon dipped about 80-90% during dot-com bubble burst in 2000. It was hard to get funding for tech companies but it returned 30,000% years later. Let's hope STX follows the same path :).

FT: Hedge funds scoop up biotech stocks after ‘catastrophic’ declines

https://www.ft.com/content/bfd7d96f-2af9-4614-b1eb-78949365de9a

FT: Hedge funds scoop up biotech stocks after ‘catastrophic’ declines

https://www.ft.com/content/bfd7d96f-2af9-4614-b1eb-78949365de9a

approx. 40% of the prescription were covered.

You are right Dave. Key investors along with LTHs are not going to let it go under. Derampers on different platforms have zero holding and they are trying to convince retail investors to sell at loss. Looks like they are getting desperate to see 5p today!!!